Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients

被引：0
|
作者：
M. C. van Maaren
L. de Munck
J. J. Jobsen
P. Poortmans
G. H. de Bock
S. Siesling
L. J. A. Strobbe
机构：
[1] Netherlands Comprehensive Cancer Organisation,Department of Research
[2] Medical Spectrum Twente,Department of Radiation Oncology
[3] Radboud University Medical Center,Department of Radiation Oncology
[4] University of Groningen,Department of Epidemiology, University Medical Center Groningen
[5] University of Twente,Department of Health Technology & Services Research, MIRA Institute for Biomedical Technology and Technical Medicine
[6] Canisius Wilhelmina Hospital,Department of Surgical Oncology
来源：
Breast Cancer Research and Treatment | 2016年 / 160卷
关键词：
Breast cancer; Breast-conserving surgery; Mastectomy; Radiation therapy; Overall survival; Relative survival; Distant metastasis-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：511 / 521
页数：10
相关论文
共 37 条
  • [21] 10-year survival in female breast cancer patients according to ER, PR and HER2 expression: a cancer registry population-based analysis
    Teresa Intrieri
    Gianfranco Manneschi
    Adele Caldarella
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4489 - 4496
  • [22] Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1-2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study
    Wang, Xiangyu
    Gao, Yinqi
    Yang, Xue
    Kong, Xiangyi
    Wang, Zixing
    Fang, Yi
    Wang, Jing
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (07) : 1262 - 1268
  • [23] Disease-Free Survival after Breast Conservation Therapy vs. Mastectomy of Patients with T1/2 Breast Cancer and No Lymph Node Metastases: Our Experience
    Fanizzi, Annarita
    Ressa, Maurizio Cosmo
    Gatta, Gianluca
    Cristofaro, Cristian
    De Santis, Valerio
    Didonna, Vittorio
    Diotaiuti, Sergio
    La Forgia, Daniele
    Petruzzellis, Nicole
    Tamborra, Pasquale
    Lorusso, Vito
    Massafra, Raffaella
    APPLIED SCIENCES-BASEL, 2021, 11 (21):
  • [24] Gene expression profiles in clinically T1-2N0 ER+HER2− breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed
    L. M. van Roozendaal
    M. L. G. Vane
    E. Colier
    L. J. A. Strobbe
    M. de Boer
    G. Sonke
    M. C. Van Maaren
    M. L. Smidt
    Breast Cancer Research and Treatment, 2024, 203 : 103 - 110
  • [25] Gene expression profiles in clinically T1-2N0 ER+HER2-breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed
    van Roozendaal, L. M.
    Vane, M. L. G.
    Colier, E.
    Strobbe, L. J. A.
    de Boer, M.
    Sonke, G.
    Van Maaren, M. C.
    Smidt, M. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (01) : 103 - 110
  • [26] Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23
    Kim, Kyubo
    Park, Hae Jin
    Shin, Kyung Hwan
    Kim, Jin Ho
    Choi, Doo Ho
    Park, Won
    Ahn, Seung Do
    Kim, Su Ssan
    Kim, Dae Yong
    Kim, Tae Hyun
    Kim, Jin Hee
    Kim, Jiyoung
    CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1316 - 1323
  • [27] Prediction of disease-free survival using strain elastography and diffuse optical tomography in patients with T1 breast cancer: a 10-year follow-up study
    Zhang, Jing
    Sun, Hao
    Gao, Song
    Kang, Ye
    Shang, Cong
    BMC CANCER, 2024, 24 (01)
  • [28] Prognosis comparison between intraoperative radiotherapy and whole-breast external beam radiotherapy for T1-2 stage breast cancer without lymph node metastasis treated with breast-conserving surgery: A case-control study after propensity score matching
    Chen, Qitong
    Qu, Limeng
    He, Yeqing
    Xu, Jiachi
    Deng, Yueqiong
    Zhou, Qin
    Yi, Wenjun
    FRONTIERS IN MEDICINE, 2022, 9
  • [29] Long-term survival of T1 and T2 lymph node-negative breast cancer patients according to mitotic activity index: A population-based study
    Louwman, WJ
    van Beek, MWPM
    Schapers, RFM
    Nolthenius-Puylaert, MBCJE
    van Diest, PJ
    Roumen, RM
    Coebergh, JWW
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (09) : 2310 - 2314
  • [30] Cause-specific mortality among patients with different molecular subtypes of T1-2N0M0 breast cancer A population-based study
    Wang, Daoliang
    Yi, Liang
    Zhang, Lijun
    Wang, Zhuo
    MEDICINE, 2021, 100 (43) : E27605
1234